Latest Headlines
-
Clinisys Moves Beyond Document Management To Laboratory Document Intelligence
10/7/2026
Clinisys, a global leader in laboratory informatics, today announced the expansion of its innovation portfolio with integrated document intelligence capabilities in Clinisys Laboratory Solution (CLS), helping laboratories capture, govern, search, and activate information across scientific and operational workflows while advancing Clinisys's vision of connected laboratory intelligence.
-
Danaher Accelerates Life Sciences Research With New AI-Powered Autonomous Lab
10/7/2026
Danaher Corporation (NYSE: DHR) today announced plans to launch its first AI-powered autonomous lab, designed to help researchers develop custom antibodies and other molecular tools faster and more efficiently.
-
Roche Diagnostics Delivers Laboratory Equipment To Support Ebola Testing In DRC
10/7/2026
As the outbreak of Ebola disease caused by Bundibugyo virus continues in the Democratic Republic of Congo (DRC), demand for testing is exceeding current available laboratory capacity, and strategic public-private partnerships are powering rapid testing and a more effective disease response.
-
Qurin Launches Qatra gDNA Extraction Kit For Large-Volume Urine Processing
10/6/2026
Qurin®, a research and development company focused on urine-based liquid biopsy diagnostics in oncology, announces the launch of the QatraTM Genomic DNA Extraction Lab Kit (RUO), developed specifically for the extraction of genomic DNA (gDNA) from large volumes of urine.
-
Bulk Peptides: Kylo Peptides Launches Bulk Research Program for High-Volume Laboratories
10/6/2026
Kylo Peptides [https://kylopeptides.com/] has introduced a research program that supplies bulk peptides to laboratories with higher-volume peptide requirements.
-
Invivoscribe Advances Molecular Clonality Testing Portfolio With Comprehensive LymphoTrack Flex Suite
10/6/2026
Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the complete LymphoTrack Flex suite, an integrated next-generation sequencing (NGS) solution to identify and track immunoglobulin and T-cell receptor gene rearrangements.
-
Werfen Launches QUANTA Link® 5.0: A Modern, Web-Based Platform For Autoimmune Laboratory Workflow Management
10/6/2026
Werfen today announced the global launch of QUANTA Link 5.0, a major advancement in its data management platform for autoimmune laboratories. The new version introduces a browser-based solution designed to simplify daily operations, improve workflow visibility, and support laboratories in managing increasing testing complexity with greater efficiency and confidence.
-
CellCarta Establishes Strategic Partnership With Waters To Advance Companion Diagnostics Development
10/5/2026
CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a strategic partnership with Waters Corporation, a global leader in life sciences and diagnostics, creating a framework to jointly pursue companion diagnostic (CDx) and next-generation flow cytometry opportunities with pharmaceutical and biotechnology companies.
-
Agilent Expands Oligonucleotide Manufacturing Capabilities With New Boulder Lab
10/5/2026
Agilent Technologies Inc. today announced the addition of new laboratory space in Boulder, Colorado, to support the expansion of its oligonucleotide manufacturing capabilities. The facility is expected to support the development and scale-up of emerging manufacturing technologies for oligonucleotide therapeutics, initially focusing on enzymatic ligation.
-
Daxor To Showcase Next-Gen Blood Volume Analyzer And New Clinical Data At HFSA 2026
10/1/2026
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announced today it will exhibit at the Heart Failure Society of America (HFSA) Annual Scientific Meeting in Phoenix, Arizona, from October 9–12, 2026.